Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.

This example shows a sample report table, trial design, and results dataset for study 123 for the determination of the in vitro genotoxicity potential of tobacco products using the in vitro micronucleus assay.  JirashowSummaryfalseserverIssue Tracker (JIRA)serverId85506ce4-3cb3-3d91-85ee-f633aaaf4a45keyTOBA-642

Expand
titleSample Report Table for Study 123

...

...

Dataset wrap
Rowcaps
Rows 1-2:Show 2 records for TSPARMCD = "GLPTYP", using TSSEQ to indicate multiple records, since both GLP types apply for this example study. 
Row 3:Shows that this study was conducted as a GLP study.
Rows 4-5:Show the study start date and study title.
Rows 6-7:Show the version of SEND Implementation Guide and version of Controlled Terminology used in this study.
Row 8:Shows the applicant's organization.
Row 9:Shows that the applicant's study reference ID is not applicable.
Rows 10-13:Show that TSGRPID has been used to link records (name, location, country) related to the test facility (TSGRPID = 1). The study director is associated with the test facility.
Rows 14-16:

Show that TSGRPID (TSGRPID=2) has been used to link the information on the testing guideline followed on this study (TSTGDNAM, TSTGDORG, TSTGDVER).

Row 17:

Shows the study type for this study.

Row 18:

Shows that this study includes a Mammalian Cell Micronucleus Assay.
Rows 19-20:Show that the species is human and the cell line is TK6 lymphoblastoid in this study.
Dataset2

Row

STUDYID

DOMAIN

TSSEQ

TSGRPID

TSPARMCD

TSPARM

TSVAL

TSVALNF

1123TS1
GLPTYPGood Laboratory Practice TypeFDA
2123TS2
GLPTYPGood Laboratory Practice TypeOECD
3123TS1
GLPFLGLP FlagY
4123TS1
STSTDTCStudy Start Date2022-05-25
5123TS1
STITLEStudy Title

Determination of the in vitro genotoxicity potential using the in vitro Neutral Red Uptake assay


6123TS1
SNDIGVERSEND Implementation Guide VersionTOBACCO IMPLEMENTATION GUIDE VERSION 1.0
7123TS1
SNDCTVERSEND Controlled Terminology VersionSEND Terminology 2021-09-30
8123TS1
APPLCNT

Applicant Organization

Jira
showSummaryfalse
serverIssue Tracker (JIRA)
serverId85506ce4-3cb3-3d91-85ee-f633aaaf4a45
keyTOBA-356
Example Applicant, Inc.
9123TS1
APREFIDStudy Reference ID
NOT APPLICABLE
10123TS11TSTFNAMTest Facility NameExample Test Lab Name
11123TS11TSTFLOCTest Facility Location10 Somewhere Street, Montgomery, AL 10000
12123TS11TFCNTRYTest Facility CountryUSA
13123TS11STDIRStudy DirectorDr. R. Smith
14123TS12TSTGDNAMTesting Guideline NameGUIDELINE FOR THE TESTING OF CHEMICALS No. 487
15123TS12TSTGDORGTesting Guideline OrganizationOECD
16123TS12TSTGDVERTesting Guideline Version29-July-2016
17123TS1
SSTYPStudy TypeGENOTOXICITY IN VITRO
18123TS1
GNTXAIDGenetic Toxicology Assay IdentifierMNvit
19123TS1
SPECIESSpeciesHUMAN
20123TS1
CELLLNCell Line

TK6 LYMPHOBLASTOID


...

Dataset wrap
Namegt
Rowcaps

Rows 1-3, 8:

Show percentage result values that apply to GTREFID=C0. REFID=C0, as shown in the RELREF dataset, relates this data to the trial set in the first row of table 1 in the sample report table for study 123.
Rows 4-7:Show the 4 micronucleated cell counts for the observational units with GTREFID from C0-Count1 through C0-Count4, for which their relationship to test conditions (in tx.xpt) and experimental units (in relref.xpt) are shown in the RELREF dataset.

Rows 9-11, 16:

Show percentage result values that apply to GTREFID=C1250. REFID=C1250, as shown in the RELREF dataset, relates this data to the trial set in the second row of table 1 in the sample report table for study 123.
Rows 12-15:Show the 4 micronucleated cell counts for the observational units with GTREFID from C1250-Count1 through C1250-Count4, for which their relationship to test conditions (in tx.xpt) and experimental units (in relref.xpt) are shown in the RELREF dataset.
Dataset2
TOBA-643

TOBA-756
RowSTUDYIDDOMAINGTSEQ

GTREFID

GTTESTCDGTTESTGTCELLEVGTORRESGTORRESU

GTCOLSRT

GTSTRESCGTSTRESNGTSTRESUGTDTC
1123GT1C0

RICC

1123GT1C0

RICC

Jira
showSummaryfalse
serverIssue Tracker (JIRA)
serverId85506ce4-3cb3-3d91-85ee-f633aaaf4a45
keyRelative Increase in Cell Count1540%
00%2022-05-25
2123GT2C0RCCRelative Cell Count1540%
00%2022-05-25
3123GT3C0RPDRelative Population Doubling1540%
00%2022-05-25
4123GT4C0-Count1MNCEMicronucleated Cells220515
Jira
showSummaryfalse
serverIssue Tracker (JIRA)
serverId85506ce4-3cb3-3d91-85ee-f633aaaf4a45
key



1515
2022-05-25
5123GT5C0-Count2MNCEMicronucleated Cells247413

1313
2022-05-25
6123GT6C0-Count3MNCEMicronucleated Cells275817

1717
2022-05-25
7123GT7C0-Count4MNCEMicronucleated Cells266912

1212
2022-05-25
8123GT8C0MNCECEMicronucleated Cells/Total Cells
0.57%
0.570.57%2022-05-25
9123GT1C1250RICCRelative Increase in Cell Count13415.7%
15.715.7%2022-05-25
10123GT2C1250RCCRelative Cell Count13413.0%
13.013.0%2022-05-25
11123GT3C1250RPDRelative Population Doubling1347.9%
7.97.9%2022-05-25
12123GT4C1250-Count1MNCEMicronucleated Cells326620

2020
2022-05-25
13123GT5C1250-Count2MNCEMicronucleated Cells219017

1717
2022-05-25
14123GT6C1250-Count3MNCEMicronucleated Cells275813

1313
2022-05-25
15123GT7C1250-Count4MNCEMicronucleated Cells271421

2121
2022-05-25
16123GT8C1250MNCECE

Micronucleated Cells/Total Cells


0.66%
0.660.66%2022-05-25